S220: REAL-WORLD OUTCOMES OF BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) FOR RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA: A CIBMTR SUBGROUP ANALYSIS BY PRIOR TREATMENT
Auteurs principaux: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Wiley
2023-08-01
|
Collection: | HemaSphere |
Accès en ligne: | http://journals.lww.com/10.1097/01.HS9.0000967792.43327.c1 |